Biophysical Methods for Biotherapeutics

Discovery and Development Applications
Herausgegeben von Das, Tapan K.

• Gebundenes Buch

Produktbeschreibung

With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development.

Helps formulation and analytical scientists in pharma and biotech better understand and use biophysical methods
Chapters organized according to the sequential nature of the drug development process
Helps formulation, analytical, and bioanalytical scientists in pharma and biotech better understand and usestrengths and limitations of biophysical methods
Explains how to use biophysical methods, the information obtained, and what needs to be presented in a regulatory filing, assess impact on quality and immunogenicity
With a focus on practical applications of biophysical techniques, this book links fundamental biophysics to the process of biopharmaceutical development.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 376
• Erscheinungstermin: 28. April 2014
• Englisch
• Abmessung: 240mm x 161mm x 25mm
• Gewicht: 739g
• ISBN-13: 9780470938430
• ISBN-10: 0470938439
• Artikelnr.: 40028967

Autorenporträt

TAPAN K. DAS is the Director of the Mass Spectrometry and Biophysics Center of Excellence in the Analytical Development and Testing group at Bristol-Myers Squibb. He is responsible for biophysical and analytical development for biotherapeutics structure-function characterization, analytical comparability, protein particulate analysis, and support for commercial biotherapeutics products. Dr. Das is also the Chair of the Biotechnology Section of Ameri an Association of Pharmaceutical Scientists.

Inhaltsangabe

Preface vii
About the Editor ix
Contributors xi
Section 1 Early Discovery Stages and Biotherapeutic Candidate Selection
1 Biophysical Methods Applied in Early Discovery of a Biotherapeutic: Case
Study of an EGFR-IGF1R Bispecific Adnectin 3
Michael L. Doyle, James W. Bryson, Virginie Lafont, Zheng Lin, Paul E.
Morin, Lumelle A. Schneeweis, Aaron P. Yamniuk, and Joseph Yanchunas Jr.
2 X-Ray Crystallography for Biotherapeutics 25
Glen Spraggon
3 Solubility and Early Assessment of Stability for Protein Therapeutics 65
Sheng-Jiun Wu, Gary L. Gilliland, and Yiqing Feng
Section 2 First-in-Human and up to Proof-of-Concept Clinical Trials
4 Biophysical and Structural Characterization Needed Prior to Proof of
Concept 95
Angela W. Blake-Haskins, Yen-Huei Lin, Zhuchun Wu, Melissa D. Perkins, and
Thomas M. Spitznagel
5 Nucleation, Aggregation, and Conformational Distortion 125
Christopher J. Roberts
6 Utilization of Chemical Labeling and Mass Spectrometry for the
Biophysical Characterization of Biopharmaceuticals 151
Justin B. Sperry and Lisa M. Jones
7 Application of Biophysical and High-Throughput Methods in the
Preformulation of Therapeutic Proteins-Facts and Fictions 173
Ahmad M. Abdul-Fattah and Hanns-Christian Mahler
8 Bioanalytical Methods and Immunogenicity Assays 207
Bonita Rup, Corinna Krinos-Fiorotti, Boris Gorovits, and Hendrik Neubert
9 Structures and Dynamics of Proteins Probed by UV Resonance Raman
Spectroscopy 243
Brian S. Leigh, Diana E. Schlamadinger, and Judy E. Kim
10 Freezing- and Drying-Induced Micro- and Nano-Heterogeneity in Biological
Solutions 269
Alptekin Aksan, Vishard Ragoonanan, and Carol Hirschmugl
Section 3 Phase III and Commercial Development
11 Late-Stage Product Characterization: Applications in Formulation,
Process, and Manufacturing Development 287
Christine P. Chan and Li Shi
12 Biophysical Analyses Suitable for Chemistry, Manufacturing, and Control
Sections of the Biologic License Application (BLA) 317
Zahra Shahrokh, Nazila Salamat-Miller, and John J. Thomas
Index 355